Clinical Trials Logo

Clinical Trial Summary

To determine the effects of topically applied ViaNOx-H for 8 hours daily for 2 weeks on the reduction of the bio-burden in biofilms on chronic non-healing wounds as recorded by measurements of wound size and wound culture.


Clinical Trial Description

The primary goal of this study is to determine the effects of topically applied gaseous nitric oxide on the bio-burden of chronic non-healing wounds of the lower extremities. Reports will include:

- Comparisons of the demographics and diagnoses of those patients treated with ViaNOx-H.

- Tabulation as to the organisms found and the bio-burden as measured by counts (0 to +4).

- Tabulation of the number and types of adverse events during ViaNOx-H treatment.

- Comparisons of the response of different organisms to ViaNOx-H treatment. ;


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00823095
Study type Interventional
Source Loma Linda University
Contact
Status Terminated
Phase Phase 2
Start date December 2005
Completion date October 2008

See also
  Status Clinical Trial Phase
Recruiting NCT05855499 - Plasma On Chronic Wounds for Epidermal Regeneration N/A
Active, not recruiting NCT04667416 - Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities Phase 2
Completed NCT02045303 - Healing Rate of Leg Wounds Treated With Contact and Noncontact Ultrasound: The VIP Ultrasound Protocol N/A